市場調査レポート

商品コード

1623959

小動物の生体内イメージング市場規模、シェア、成長分析、モダリティ別、試薬別、用途別、エンドユーザー別、地域別 - 産業予測、2025-2032年

Small Animal Imaging In Vivo Market Size, Share, Growth Analysis, By Modality, By Reagents, By Application, By End-User, By Region - Industry Forecast 2025-2032

出版日: 2025年01月03日
発行: SkyQuest
ページ情報: 英文 224 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の小動物の生体内イメージング市場規模は、2023年に10億7,000万米ドルと評価され、2024年の11億5,000万米ドルから2032年には21億米ドルに成長し、予測期間（2025-2032年）のCAGRは7.8％で成長する見通しです。

核医学イメージング技術市場は、マイクロMRI、マイクロCT、マイクロPETなどのマイクロレベルの装置、マルチモーダルイメージング、マイクロ超音波や光学イメージングなどの新興技術の進歩によって進化しています。市場成長の主な促進要因としては、製薬投資の増加や前臨床研究のニーズが挙げられます。しかし、特にインフラや熟練した人材が不十分な新興経済諸国では、厳しい規制や不十分な償還が課題となっています。北米は、有利な償還政策と先進イメージング・システムへの多額の投資により、世界市場の35%を占め、リードしています。一方、アジア太平洋地域はCAGR 11.5%と堅調な成長が見込まれています。COVID-19パンデミックはサプライチェーンと需要を一時的に混乱させ、市場ダイナミクスに影響を与えています。全体として、手頃な価格の技術商業化は業界の拡大にとって引き続き重要です。

市場概要
光学画像システム
- 生物発光イメージング
- 蛍光イメージング
核イメージングシステム
- 陽電子放出断層撮影（PET）
- 単一光子放出コンピュータ断層撮影（SPECT）
磁気共鳴画像（MRI）システム
コンピュータ断層撮影（CT）システム
超音波画像診断システム
光音響イメージングシステム

小動物の生体内イメージング市場規模：試薬別

市場概要
光学イメージング試薬
核イメージング試薬
MRI造影剤
超音波造影剤
CT造影剤

小動物の生体内イメージング市場規模：用途別

市場概要
生体内分布研究
がん細胞の検出
バイオマーカー
縦断的研究
医薬品開発
機能的および解剖学的画像

小動物の生体内イメージング市場規模：エンドユーザー別

市場概要
製薬・バイオテクノロジー企業
学術調査機関
契約調査機関（CRO）
病院と診療所

小動物の生体内イメージング市場規模

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2022-2024）

主要企業プロファイル

Bruker Corporation（US）
PerkinElmer, Inc.（US）
FUJIFILM Holdings Corporation（Japan）
Siemens Healthineers AG（Germany）
Miltenyi Biotec（Germany）
Aspect Imaging（Israel）
Thermo Fisher Scientific Inc.（US）
GE Healthcare（US）
Mediso Ltd.（Hungary）
MR Solutions Ltd.（UK）
TriFoil Imaging（US）
Key Developments
Agilent Technologies, Inc.（US）
Hitachi Ltd.（Japan）
Canon Medical Systems Corporation（Japan）

結論と推奨事項

Product Code: SQSG35A2089

Global Small Animal Imaging In Vivo Market size was valued at USD 1.07 billion in 2023 and is poised to grow from USD 1.15 billion in 2024 to USD 2.1 billion by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).

The nuclear imaging technology market is evolving with advancements in micro-level equipment, including micro MRI, micro CT, and micro PET, as well as multimodal imaging and emerging techniques like micro-ultrasound and optical imaging. Key drivers of market growth include increasing pharmaceutical investments and pre-clinical research needs. However, stringent regulations and inadequate reimbursement pose challenges, particularly in developing economies with insufficient infrastructure and skilled personnel. North America leads, dominating the global market with a 35% share due to favorable reimbursement policies and significant investments in advanced imaging systems. Meanwhile, the Asia-Pacific region is anticipated to experience robust growth at a CAGR of 11.5%. The COVID-19 pandemic has temporarily disrupted supply chains and demand, impacting market dynamics. Overall, affordable technology commercialization remains crucial for industry expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Small Animal Imaging In Vivo market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Small Animal Imaging In Vivo Market Segmental Analysis

Global Small Animal Imaging In Vivo Market is segmented by Modality, Reagents, Application, End-User and region. Based on Modality, the market is segmented into Optical Imaging Systems, Nuclear Imaging Systems, Magnetic Resonance Imaging (MRI) Systems, Computed Tomography (CT) Systems, Ultrasound Imaging Systems and Photoacoustic Imaging Systems. Based on Reagents, the market is segmented into Optical Imaging Reagents, Nuclear Imaging Reagents, MRI Contrast Agents, Ultrasound Contrast Agents and CT Contrast Agents. Based on Application, the market is segmented into Biodistribution Studies, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Drug Development and Functional and Anatomical Imaging. Based on End-User, the market is segmented into Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs) and Hospitals and Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Small Animal Imaging In Vivo Market

The global Small Animal Imaging In Vivo market is poised for growth driven by several key factors. The increasing adoption of multimodal imaging technologies is anticipated to significantly enhance market expansion throughout the forecast period. Additionally, rising healthcare expenditures are expected to bolster the small animal imaging sector. The preference for non-invasive imaging solutions is also gaining traction, further propelling market growth. Contributing factors include higher disposable incomes and urbanization trends, which create a more conducive environment for technological advancements. Furthermore, the growing investment in healthcare infrastructure is a significant driving force, particularly in oncology applications, as cancer rates rise worldwide.

Restraints in the Global Small Animal Imaging In Vivo Market

The growth of the small animal in vivo imaging market is anticipated to be hampered by several factors during the projected period. Key restraints include the high costs associated with imaging equipment and existing technological limitations. Additionally, there is a significant shortage of skilled professionals in emerging markets, compounded by insufficient research facilities and infrastructure. The market will also encounter challenges due to low healthcare expenditure in developing countries and the absence of standardized practices. Furthermore, limited awareness and a scarcity of qualified experts will constrain the overall growth rate of the small animal imaging sector from 2022 to 2028.

Market Trends of the Global Small Animal Imaging In Vivo Market

The Global Small Animal Imaging In Vivo market is experiencing significant growth driven by the surging demand for non-invasive imaging techniques. This trend is propelled by the expansion of pharmaceutical companies and research institutions, bolstered by funding from public and private sectors for innovative developments. Moreover, advancements across multiple disciplines such as chemistry, computer science, engineering, medicine, and molecular biology are enhancing imaging capabilities. The period from 2021 to 2028 is expected to witness further opportunities, particularly due to rising demand in emerging economies and intensified R&D initiatives, positioning the market for sustained expansion and innovation.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Technology Advancement
Regulatory Landscape

Global Small Animal Imaging In Vivo Market Size by Modality & CAGR (2025-2032)

Market Overview
Optical Imaging Systems
- Bioluminescence Imaging
- Fluorescence Imaging
Nuclear Imaging Systems
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
Magnetic Resonance Imaging (MRI) Systems
Computed Tomography (CT) Systems
Ultrasound Imaging Systems
Photoacoustic Imaging Systems

Global Small Animal Imaging In Vivo Market Size by Reagents & CAGR (2025-2032)

Market Overview
Optical Imaging Reagents
Nuclear Imaging Reagents
MRI Contrast Agents
Ultrasound Contrast Agents
CT Contrast Agents

Global Small Animal Imaging In Vivo Market Size by Application & CAGR (2025-2032)

Market Overview
Biodistribution Studies
Cancer Cell Detection
Biomarkers
Longitudinal Studies
Drug Development
Functional and Anatomical Imaging

Global Small Animal Imaging In Vivo Market Size by End-User & CAGR (2025-2032)

Market Overview
Pharmaceutical and Biotechnology Companies
Academic and Research Institutions
Contract Research Organizations (CROs)
Hospitals and Clinics

Global Small Animal Imaging In Vivo Market Size & CAGR (2025-2032)

North America (Modality, Reagents, Application, End-User)
- US
- Canada
Europe (Modality, Reagents, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Modality, Reagents, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Modality, Reagents, Application, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Modality, Reagents, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Bruker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FUJIFILM Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aspect Imaging (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mediso Ltd. (Hungary)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MR Solutions Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TriFoil Imaging (US)
- Company Overview
- Business Segment Overview
- Financial Updates
Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hitachi Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Canon Medical Systems Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments